Shell Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Sell |
5,282
-6,767
| -56% | -$88.4K | ﹤0.01% | 1080 |
|
|
2025
Q1 | $128K | Sell |
12,049
-505
| -4% | -$5.37K | 0.01% | 948 |
|
|
2024
Q4 | $213K | Hold |
12,554
| – | – | 0.01% | 817 |
|
|
2024
Q3 | $291K | Buy |
+12,554
| New | +$291K | 0.01% | 702 |
|
|
2024
Q1 | $313K | Sell |
12,869
-3,905
| -23% | -$95K | 0.01% | 665 |
|
|
2023
Q4 | $529K | Sell |
16,774
-5,030
| -23% | -$159K | 0.02% | 496 |
|
|
2023
Q3 | $557K | Sell |
21,804
-377
| -2% | -$9.63K | 0.02% | 518 |
|
|
2023
Q2 | $636K | Sell |
22,181
-7,517
| -25% | -$216K | 0.03% | 496 |
|
|
2023
Q1 | $712K | Buy |
29,698
+13,843
| +87% | +$332K | 0.03% | 449 |
|
|
2022
Q4 | $269K | Buy |
+15,855
| New | +$269K | 0.01% | 819 |
|
|
2020
Q4 | – | Sell |
-1,510
| Closed | -$65K | – | 1435 |
|
|
2020
Q3 | $65K | Hold |
1,510
| – | – | ﹤0.01% | 1236 |
|
|
2020
Q2 | $71K | Buy |
+1,510
| New | +$71K | ﹤0.01% | 1197 |
|